Immature teratoma
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Immature teratoma | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Abdominal pain, palpable mass, bloating |
| Complications | Metastasis, recurrence |
| Onset | Typically in young women |
| Duration | Variable |
| Types | |
| Causes | Unknown |
| Risks | |
| Diagnosis | Histopathology, imaging studies |
| Differential diagnosis | Mature teratoma, dysgerminoma, yolk sac tumor |
| Prevention | |
| Treatment | Surgery, chemotherapy |
| Medication | |
| Prognosis | Depends on stage and grade |
| Frequency | Rare |
| Deaths | N/A |
Immature teratoma is a rare, malignant type of germ cell tumor characterized by the presence of immature (embryonic) tissues, most commonly neuroectodermal elements. It most frequently arises in the ovary but may also occur in the testis or other midline structures.
Overview[edit]
Teratomas are tumors derived from pluripotent germ cells that can differentiate into tissues from all three germ layers:
Unlike mature teratomas (dermoid cysts), which contain well-differentiated tissues and are usually benign, immature teratomas contain incompletely differentiated tissues and have malignant potential.
Epidemiology[edit]
Immature teratomas are uncommon but represent an important subset of ovarian tumors in younger individuals.
- Most commonly occur in adolescents and young women
- Account for a small percentage of all ovarian tumors
- Rare in males but may occur in the testis
Etiology[edit]
Immature teratomas arise from primordial germ cells that fail to differentiate properly. The exact cause is not fully understood, but involves:
- Abnormal germ cell development
- Genetic and molecular alterations affecting differentiation
Pathophysiology[edit]
The defining feature of immature teratoma is the presence of immature embryonic tissue, especially:
- Immature neuroepithelium
- Primitive mesenchymal tissue
- Undifferentiated glandular structures
Tumor behavior depends on:
- Degree of immaturity (grade)
- Extent of spread (stage)
Higher grades are associated with more aggressive behavior.
Classification[edit]
Immature teratomas are graded histologically based on the amount of immature tissue present.
Grading[edit]
- Grade 1 – limited immature tissue
- Grade 2 – moderate immature tissue
- Grade 3 – abundant immature tissue
Higher grade correlates with higher malignant potential.
Signs and symptoms[edit]
Clinical presentation varies but commonly includes:
- Abdominal or pelvic pain
- Palpable mass
- Abdominal distension
- Nausea or vomiting
- Menstrual irregularities (in ovarian cases)
In testicular cases:
- Testicular mass
- Scrotal swelling
Diagnosis[edit]
Diagnosis involves a combination of clinical evaluation, imaging, tumor markers, and histopathology.
Imaging[edit]
- Ultrasound – initial evaluation
- Computed tomography (CT)
- Magnetic resonance imaging (MRI)
Findings may show a complex mass with solid and cystic components.
Tumor markers[edit]
Markers may be elevated depending on tumor components:
- Alpha-fetoprotein (AFP)
- Human chorionic gonadotropin (hCG)
Histopathology[edit]
Definitive diagnosis requires microscopic examination demonstrating:
- Immature neural tissue
- Primitive structures
- Mixed tissue elements from different germ layers
Differential diagnosis[edit]
Conditions to consider include:
Treatment[edit]
Management depends on stage and grade.
Surgery[edit]
Primary treatment involves surgical removal:
- Ovarian tumor resection (often fertility-sparing in young patients)
- Staging procedures to assess spread
Chemotherapy[edit]
Used in:
- Higher-grade tumors
- Advanced-stage disease
Common regimens include combination chemotherapy used for germ cell tumors.
Prognosis[edit]
Prognosis is generally favorable, especially when detected early.
Factors influencing outcome:
- Tumor grade
- Stage at diagnosis
- Completeness of surgical removal
Survival rates are high for early-stage, low-grade tumors.
Complications[edit]
Potential complications include:
- Recurrence
- Metastasis
- Tumor rupture
- Ascites
- Infertility (depending on treatment)
Follow-up[edit]
Regular follow-up is important and may include:
- Imaging studies
- Tumor marker monitoring
- Clinical examination
See also[edit]
External links[edit]
| Overview of tumors, cancer and oncology | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
